Thalidomide and the Power of the Drug Companies PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Thalidomide and the Power of the Drug Companies PDF full book. Access full book title Thalidomide and the Power of the Drug Companies by Henning Sjöström. Download full books in PDF and EPUB format.
Author: Henning Sjöström
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 294
Get Book Here
Book Description
Author: Henning Sjöström
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 294
Get Book Here
Book Description
Author: Trent Stephens
Publisher: Basic Books
ISBN: 0786731125
Category : Science
Languages : en
Pages : 244
Get Book Here
Book Description
In this riveting medical detective story, Trent Stephens and Rock Brynner recount the history of thalidomide, from the epidemic of birth defects in the 1960's to the present day, as scientists work to create and test an alternative drug that captures thalidomide's curative properties without its cruel side effects. A parable about compassion-and the absence of it-Dark Remedy is a gripping account of thalidomide's extraordinary impact on the lives of individuals and nations over half a century.
Author: Ellen F. M. 't Hoen
Publisher:
ISBN: 9789079700066
Category : Agreement on Trade-Related Aspects of Intellectual Property Rights
Languages : en
Pages : 136
Get Book Here
Book Description
In The Global Politics of Pharmaceutical Monopoly Power, researcher and global advocate Ellen 't Hoen explains how new global rules for pharmaceutical patenting impact access to medicines in the developing world. The book gives an account of the current debates on intellectual property, access to medicines, and medical innovation, and provides historical context that explains how the current system emerged. This book supports major policy changes in the management of pharmaceutical patents and the way medical innovation is financed in order to protect public health and, in particular, promote access to essential medicines for all. The Open Society Institute provided support to translate this report into Russian.
Author: Melody Petersen
Publisher: Sarah Crichton Books
ISBN: 142994403X
Category : Business & Economics
Languages : en
Pages : 450
Get Book Here
Book Description
In the last thirty years, the big pharmaceutical companies have transformed themselves into marketing machines selling dangerous medicines as if they were Coca-Cola or Cadillacs. They pitch drugs with video games and soft cuddly toys for children; promote them in churches and subways, at NASCAR races and state fairs. They've become experts at promoting fear of disease, just so they can sell us hope. No question: drugs can save lives. But the relentless marketing that has enriched corporate executives and sent stock prices soaring has come with a dark side. Prescription pills taken as directed by physicians are estimated to kill one American every five minutes. And that figure doesn't reflect the damage done as the overmedicated take to the roads. Our Daily Meds connects the dots for the first time to show how corporate salesmanship has triumphed over science inside the biggest pharmaceutical companies and, in turn, how this promotion driven industry has taken over the practice of medicine and is changing American life. It is an ageless story of the battle between good and evil, with potentially life-changing consequences for everyone, not just the 65 percent of Americans who unscrew a prescription cap every day. An industry with the promise to help so many is now leaving a legacy of needless harm.
Author: Daniel Carpenter
Publisher: Princeton University Press
ISBN: 1400835119
Category : Political Science
Languages : en
Pages : 825
Get Book Here
Book Description
How the FDA became the world's most powerful regulatory agency The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuticals while resisting efforts to curb its own authority. Carpenter explains how the FDA's reputation and power have played out among committees in Congress, and with drug companies, advocacy groups, the media, research hospitals and universities, and governments in Europe and India. He shows how FDA regulatory power has influenced the way that business, medicine, and science are conducted in the United States and worldwide. Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA's waning influence in drug regulation today. Reputation and Power demonstrates how reputation shapes the power and behavior of government agencies, and sheds new light on how that power is used and contested. Some images inside the book are unavailable due to digital copyright restrictions.
Author: John Braithwaite
Publisher: Routledge
ISBN: 1135072906
Category : Social Science
Languages : en
Pages : 451
Get Book Here
Book Description
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309498511
Category : Medical
Languages : en
Pages : 103
Get Book Here
Book Description
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Author: Georgina D. Feldberg
Publisher: McGill-Queen's Press - MQUP
ISBN: 9780773525016
Category : Health & Fitness
Languages : en
Pages : 454
Get Book Here
Book Description
This book examines North American women's engagement with their health systems and asks to what extent national citizenship has shaped women's health. Authors provide a much-needed analysis of the dynamic decades after 1945, when both Canada and the United States began using federal funds to expand health-care access and biomedical research and authority reached new heights. (Midwest).
Author: Graham Dukes
Publisher: Edward Elgar Publishing
ISBN: 1783471107
Category : Business & Economics
Languages : en
Pages : 419
Get Book Here
Book Description
The pharmaceutical industry exists to serve the community, but over the years it has engaged massively in corporate crime, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health documents the pr
Author: Michael Magazanik
Publisher: Text Publishing
ISBN: 1925095096
Category : Social Science
Languages : en
Pages : 355
Get Book Here
Book Description
The baby started to come out. Head first, everything OK. But then I saw that there were no arms. And then no legs. The little girl had only a torso and a head. Lyn Rowe was born in Melbourne in 1962, seven months after her mother Wendy was given a new wonder drug for morning sickness called thalidomide. For fifty years the Rowe family cared for Lyn. Decades of exhausting, round-the-clock work. But then in 2011 Lyn Rowe launched a legal claim against the thalidomide companies. Against the odds, she won a multi-million-dollar settlement. Former journalist Michael Magazanik is one of the lawyers who ran Lyn’s case. In Silent Shock he exposes a fifty-year cover up concerning history’s most notorious drug, and details not only the damning case against manufacturers Grünenthal—whose enthusiastic promotion of their lucrative drug in the face of mounting evidence beggars belief—but also the moving story of the Rowe family. Spanning Australia, the United States, the United Kingdom, Japan, Canada, Sweden and, of course, Germany, Silent Shock is an epic account of corporate wrongdoing against a backdrop of heroic personal struggle and sacrifice. Michael Magazanik has worked as a journalist for the Age, the Australian and ABC-TV, and is now a lawyer with Slater & Gordon. He lives in Melbourne with his partner and three children. ‘Magazanik exposes myths and concealments on a grand scale... A compelling read. Highly recommended.’ BookMooch ‘Magazanik—a lawyer on the Rowes’ legal team and a former journalist—has woven an extraordinary story...Magazanik has moulded [the Rowes'] story into a modern Australian myth, the battlers who took on the pharmaceuticals and won.' Age/Sydney Morning Herald ‘A harrowing read of the damage wrought by this infamous drug.’ WA Today ‘A frightening account of secrets in the pharmaceutical industry and the inspiring story of a family and their legal team that just wouldn't give up.’ Law Society Journal ‘Silent Shock is an ambitious, important book...Magazanik does an excellent job.’ Australian Book Review
